[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to main content

Advertisement

Log in

Resveratrol and Sir2 Reverse Sleep and Memory Defects Induced by Amyloid Precursor Protein

  • Original Article
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

Abstract

Resveratrol (RES), a natural polyphenolic phytochemical, has been suggested as a putative anti-aging molecule for the prevention and treatment of Alzheimer’s disease (AD) by the activation of sirtuin 1 (Sirt1/Sir2). In this study, we tested the effects of RES and Sirt1/Sir2 on sleep and courtship memory in a Drosophila model by overexpression of amyloid precursor protein (APP), whose duplications and mutations cause familial AD. We found a mild but significant transcriptional increase of Drosophila Sir2 (dSir2) by RES supplementation for up to 17 days in APP flies, but not for 7 days. RES and dSir2 almost completely reversed the sleep and memory deficits in APP flies. We further demonstrated that dSir2 acts as a sleep promotor in Drosophila neurons. Interestingly, RES increased sleep in the absence of dSir2 in dSir2-null mutants, and RES further enhanced sleep when dSir2 was either overexpressed or knocked down in APP flies. Finally, we showed that Aβ aggregates in APP flies were reduced by RES and dSir2, probably via inhibiting Drosophila β-secretase (dBACE). Our data suggest that RES rescues the APP-induced behavioral deficits and Aβ burden largely, but not exclusively, via dSir2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000, 289: 2126–2128.

    Article  CAS  PubMed  Google Scholar 

  2. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004, 305: 390–392.

    Article  CAS  PubMed  Google Scholar 

  3. Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature 2009, 460: 587–591.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425: 191–196.

    Article  CAS  PubMed  Google Scholar 

  5. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004, 430: 686–689.

    Article  CAS  PubMed  Google Scholar 

  6. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 2008, 8: 157–168.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Sawda C, Moussa C, Turner RS. Resveratrol for Alzheimer’s disease. Ann N Y Acad Sci 2017, 1403: 142–149.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Fantacuzzi M, Amoroso R, Carradori S, De Filippis B. Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy. Eur J Med Chem 2022, 233: 114242.

    Article  CAS  PubMed  Google Scholar 

  9. Khan H, Tiwari P, Kaur A, Singh TG. Sirtuin acetylation and deacetylation: A complex paradigm in neurodegenerative disease. Mol Neurobiol 2021, 58: 3903–3917.

    Article  CAS  PubMed  Google Scholar 

  10. Lutz MI, Milenkovic I, Regelsberger G, Kovacs GG. Distinct patterns of sirtuin expression during progression of Alzheimer’s disease. Neuromol Med 2014, 16: 405–414.

    Article  CAS  Google Scholar 

  11. Yin J, Han P, Song M, Nielsen M, Beach TG, Serrano GE, et al. Amyloid-β increases tau by mediating sirtuin 3 in Alzheimer’s disease. Mol Neurobiol 2018, 55: 8592–8601.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Julien C, Tremblay C, Émond V, Lebbadi M, Salem N, Bennett DA, et al. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol 2009, 68: 48–58.

    Article  CAS  PubMed  Google Scholar 

  13. Brown BM, Rainey-Smith SR, Villemagne VL, Weinborn M, Bucks RS, Sohrabi HR, et al. The relationship between sleep quality and brain amyloid burden. Sleep 2016, 39: 1063–1068.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Branger P, Arenaza-Urquijo EM, Tomadesso C, Mézenge F, André C, de Flores R, et al. Relationships between sleep quality and brain volume, metabolism, and amyloid deposition in late adulthood. Neurobiol Aging 2016, 41: 107–114.

    Article  CAS  PubMed  Google Scholar 

  15. Kent BA, Feldman HH, Nygaard HB. Sleep and its regulation: An emerging pathogenic and treatment frontier in Alzheimer’s disease. Prog Neurobiol 2021, 197: 101902.

    Article  PubMed  Google Scholar 

  16. Ping Y, Hahm ET, Waro G, Song Q, Vo-Ba DA, Licursi A, et al. Linking aβ42-induced hyperexcitability to neurodegeneration, learning and motor deficits, and a shorter lifespan in an Alzheimer’s model. PLoS Genet 2015, 11: e1005025.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Fossgreen A, Brückner B, Czech C, Masters CL, Beyreuther K, Paro R. Transgenic Drosophila expressing human amyloid precursor protein show gamma-secretase activity and a blistered-wing phenotype. Proc Natl Acad Sci U S A 1998, 95: 13703–13708.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Shao L, Zhang Y, Ping Hao Y. Upregulation of IP3 receptor mediates APP-induced defects in synaptic downscaling and sleep homeostasis. Cell Rep 2022, 38: 110594.

    Article  CAS  PubMed  Google Scholar 

  19. Griswold AJ, Chang KT, Runko AP, Knight MA, Min KT. Sir2 mediates apoptosis through JNK-dependent pathways in Drosophila. Proc Natl Acad Sci U S A 2008, 105: 8673–8678.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Feng G, Pang J, Yi X, Song Q, Zhang J, Li C, et al. Down-regulation of KV4 channel in Drosophila mushroom body neurons contributes to Aβ42-induced courtship memory deficits. Neuroscience 2018, 370: 236–245.

    Article  CAS  PubMed  Google Scholar 

  21. Raun N, Jones S, Kramer JM. Conditioned courtship suppression in Drosophila melanogaster. J Neurogenet 2021, 35: 154–167.

    Article  PubMed  Google Scholar 

  22. Zhuang L, Peng F, Huang Y, Li W, Huang J, Chu Y, et al. CHIP modulates APP-induced autophagy-dependent pathological symptoms in Drosophila. Aging Cell 2020, 19: e13070.

    Article  CAS  PubMed  Google Scholar 

  23. Ren R, Qi J, Lin S, Liu X, Yin P, Wang Z, et al. The China Alzheimer report 2022. Gen Psychiatr 2022, 35: e100751.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Martens YA, Zhao N, Liu CC, Kanekiyo T, Yang AJ, Goate AM, et al. ApoE Cascade Hypothesis in the pathogenesis of Alzheimer’s disease and related dementias. Neuron 2022, 110: 1304–1317.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Busche MA, Hyman BT. Synergy between amyloid-β and tau in Alzheimer’s disease. Nat Neurosci 2020, 23: 1183–1193.

    Article  CAS  PubMed  Google Scholar 

  26. Li Y, Shao L, Mou Y, Zhang Y, Ping Y. Sleep, circadian rhythm and gut microbiota: Alterations in Alzheimer’s disease and their potential links in the pathogenesis. Gut Microbes 2021, 13: 1957407.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Cai W, Li L, Sang S, Pan X, Zhong C. Physiological roles of β-amyloid in regulating synaptic function: Implications for AD pathophysiology. Neurosci Bull 2022, https://doi.org/10.1007/s12264-022-00985-9.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Jia J, Xu J, Liu J, Wang Y, Wang Y, Cao Y, et al. Comprehensive management of daily living activities, behavioral and psychological symptoms, and cognitive function in patients with Alzheimer’s disease: A Chinese consensus on the comprehensive management of Alzheimer’s disease. Neurosci Bull 2021, 37: 1025–1038.

    Article  PubMed  PubMed Central  Google Scholar 

  29. El Gaamouch F, Liu K, Lin HY, Wu C, Wang J. Development of grape polyphenols as multi-targeting strategies for Alzheimer’s disease. Neurochem Int 2021, 147: 105046.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Wang C, Wheeler CT, Alberico T, Sun X, Seeberger J, Laslo M, et al. The effect of resveratrol on lifespan depends on both gender and dietary nutrient composition in Drosophila melanogaster. Age (Dordr) 2013, 35: 69–81.

    Article  CAS  PubMed  Google Scholar 

  31. Shukla N, Kolthur-Seetharam U. Drosophila Sirtuin 6 mediates developmental diet-dependent programming of adult physiology and survival. Aging Cell 2022, 21: e13576.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Chan V, Lo K. Efficacy of dietary supplements on improving sleep quality: A systematic review and meta-analysis. Postgrad Med J 2022, 98: 285–293.

    Article  PubMed  Google Scholar 

  33. Pennisi M, Bertino G, Gagliano C, Malaguarnera M, Bella R, Borzì AM, et al. Resveratrol in hepatitis C patients treated with pegylated-interferon-α-2b and ribavirin reduces sleep disturbance. Nutrients 2017, 9: 897.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Wightman EL, Haskell-Ramsay CF, Reay JL, Williamson G, Dew T, Zhang W, et al. The effects of chronic trans-resveratrol supplementation on aspects of cognitive function, mood, sleep, health and cerebral blood flow in healthy, young humans. Br J Nutr 2015, 114: 1427–1437.

    Article  CAS  PubMed  Google Scholar 

  35. de Ligt M, Bergman M, Fuentes RM, Essers H, Moonen-Kornips E, Havekes B, et al. No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: A randomized trial. Am J Clin Nutr 2020, 112: 1029–1038.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Panossian L, Fenik P, Zhu Y, Zhan G, McBurney MW, Veasey S. SIRT1 regulation of wakefulness and senescence-like phenotype in wake neurons. J Neurosci 2011, 31: 4025–4036.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Satoh A, Brace CS, Rensing N, Cliften P, Wozniak DF, Herzog ED, et al. Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab 2013, 18: 416–430.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Wang R, Zhang Y, Li J, Zhang C. Resveratrol ameliorates spatial learning memory impairment induced by Aβ1-42 in rats. Neuroscience 2017, 344: 39–47.

    Article  CAS  PubMed  Google Scholar 

  39. Qi Y, Shang L, Liao Z, Su H, Jing H, Wu B, et al. Intracerebroventricular injection of resveratrol ameliorated Aβ-induced learning and cognitive decline in mice. Metab Brain Dis 2019, 34: 257–266.

    Article  CAS  PubMed  Google Scholar 

  40. Pyo IS, Yun S, Yoon YE, Choi JW, Lee SJ. Mechanisms of aging and the preventive effects of resveratrol on age-related diseases. Molecules 2020, 25: 4649.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Farzaei MH, Rahimi R, Nikfar S, Abdollahi M. Effect of resveratrol on cognitive and memory performance and mood: A meta-analysis of 225 patients. Pharmacol Res 2018, 128: 338–344.

    Article  PubMed  Google Scholar 

  42. Köbe T, Witte AV, Schnelle A, Tesky VA, Pantel J, Schuchardt JP, et al. Impact of resveratrol on glucose control, hippocampal structure and connectivity, and memory performance in patients with mild cognitive impairment. Front Neurosci 2017, 11: 105.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Michán S, Li Y, Chou MMH, Parrella E, Ge H, Long JM, et al. SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci 2010, 30: 9695–9707.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Gong B, Pan Y, Vempati P, Zhao W, Knable L, Ho L, et al. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer’s mouse models. Neurobiol Aging 2013, 34: 1581–1588.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Marambaud P, Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer’s disease amyloid-beta peptides. J Biol Chem 2005, 280: 37377–37382.

    Article  CAS  PubMed  Google Scholar 

  46. Wu Z, Wu A, Dong J, Sigears A, Lu B. Grape skin extract improves muscle function and extends lifespan of a Drosophila model of Parkinson’s disease through activation of mitophagy. Exp Gerontol 2018, 113: 10–17.

    Article  CAS  PubMed  Google Scholar 

  47. Bhullar KS, Hubbard BP. Lifespan and healthspan extension by resveratrol. Biochim Biophys Acta 2015, 1852: 1209–1218.

    Article  CAS  PubMed  Google Scholar 

  48. Cheng X, Song C, Du Y, Gaur U, Yang M. Pharmacological treatment of Alzheimer’s disease: Insights from Drosophila melanogaster. Int J Mol Sci 2020, 21: 4621.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Long J, Gao H, Sun L, Liu J, Zhao-Wilson X. Grape extract protects mitochondria from oxidative damage and improves locomotor dysfunction and extends lifespan in a Drosophila Parkinson’s disease model. Rejuvenation Res 2009, 12: 321–331.

    Article  CAS  PubMed  Google Scholar 

  50. Staats S, Wagner AE, Kowalewski B, Rieck FT, Soukup ST, Kulling SE, et al. Dietary resveratrol does not affect life span, body composition, stress response, and longevity-related gene expression in Drosophila melanogaster. Int J Mol Sci 2018, 19: 223.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Whitaker R, Faulkner S, Miyokawa R, Burhenn L, Henriksen M, Wood JG, et al. Increased expression of Drosophila Sir2 extends life span in a dose-dependent manner. Aging (Albany NY) 2013, 5: 682–691.

    Article  PubMed  Google Scholar 

  52. Burnett C, Valentini S, Cabreiro F, Goss M, Somogyvári M, Piper MD, et al. Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 2011, 477: 482–485.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Guarente L. Sirtuins and ageing—new findings. EMBO Rep 2013, 14: 750.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the Bloomington Stock Center for the fly stocks used in this study. This work was funded by grants from the National Natural Science Foundation of China (81970999), the Shanghai Rising-Star Program (19QA1404900), and the Innovation Program of the Shanghai Municipal Education Commission (2019-01-07-00-02-E00037).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yong Ping.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hao, Y., Shao, L., Hou, J. et al. Resveratrol and Sir2 Reverse Sleep and Memory Defects Induced by Amyloid Precursor Protein. Neurosci. Bull. 39, 1117–1130 (2023). https://doi.org/10.1007/s12264-023-01056-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-023-01056-3

Keywords

Navigation